Evaluation of four methods used to measure plasma insulin-like growth factor 1 concentrations in healthy cats and cats with diabetes mellitus or other diseases

American Journal of Veterinary Research

Volumn 73, Issue 12, 2012, Pages 1925-1931

  Tschuor, Flurin ^a,b   Zini, Eric ^a   Schellenberg, Stefan ^c   Wenger, Monique ^c   Boretti, Felicitas S ^a   Reusch, Claudia E ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b BolligerTschuor AG   (Switzerland)

^c Tierklinik Aarau West ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ACCURACY; ACIDIFICATION; ANIMAL EXPERIMENT; ARTICLE; CAT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HYPERTHYROIDISM; IMMUNORADIOMETRIC ASSAY; MALE; NONHUMAN; RADIOIMMUNOASSAY;

ANIMALS; CAT DISEASES; CATS; DIABETES MELLITUS; FEMALE; INSULIN-LIKE GROWTH FACTOR I; LUMINESCENT MEASUREMENTS; MALE; RADIOIMMUNOASSAY;

ANIMALIA;

EID: 84870461664     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.73.12.1925     Document Type: Article

References (27)

1. Reusch CE, Kley S, Casella M, et al. Measurements of growth hormone and insulin-like growth factor 1 in cats with diabetes mellitus. Vet Rec 2006;158:195-200.
2. Lewitt MS, Hazel SJ, Church DB, et al. Regulation of insulinlike growth factor-binding protein-3 ternary complex in feline diabetes mellitus. J Endocrinol 2000;166:21-27.
3. Alt N, Kley S, Tschuor F, et al. Evaluation of IGF-1 levels in cats with transient and permanent diabetes mellitus. Res Vet Sci 2007;83:331-335.
4. Starkey SR, Tan K, Church DB. Investigation of serum IGF-I levels amongst diabetic and non-diabetic cats. J Feline Med Surg 2004;6:149-155.
5. Berg RI, Nelson RW, Feldman EC, et al. Serum insulin-like growth factor-I concentration in cats with diabetes mellitus and acromegaly. J Vet Intern Med 2007;21:892-898.
6. Niessen SJ, Petrie G, Gaudiano F, et al. Feline acromegaly: an underdiagnosed endocrinopathy? J Vet Intern Med 2007;21:899-905.
7. Blum WF, Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regul 1994;4(suppl 1):11-19.
8. Chestnut RE, Quarmby V. Evaluation of total IGF-I assay methods using samples from type I and type II diabetic patients. J Immunol Methods 2002;259:11-24.
9. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 2003;13:113-170.
10. Zapf J, Gosteli-Peter M, Weckbecker G, et al. The somatostatin analog octreotide inhibits GH-stimulated, but not IGF-I-stimulated, bone growth in hypophysectomized rats. Endocrinology 2002;143:2944-2952.
11. Frystyk J, Freda P, Clemmons DR. The current status of IGF-I assays-a 2009 update. Growth Horm IGF Res 2010;20:8-18.
12. Clemmons DR. IGF-I assays: current assay methodologies and their limitations. Pituitary 2007;10:121-128.
13. Juul A, Dalgaard P, Blum WF, et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-2542.
14. Kaplowitz PB, D'Ercole AJ, Van Wyk JJ, et al. Plasma somatomedin-C during the first year of life. J Pediatr 1982;100:932-934.
15. Low LC, Tam SY, Kwan EY, et al. Onset of significant GH dependence of serum IGF-I and IGF-binding protein 3 concentrations in early life. Pediatr Res 2001;50:737-742.
16. Radetti G, Paganini C, Antoniazzi F, et al. Growth hormonebinding proteins, IGF-I and IGF-binding proteins in children and adolescents with type 1 diabetes mellitus. Horm Res 1997;47:110-115.
17. Dunger DB, Acerini CL. IGF-I and diabetes in adolescence. Diabetes Metab 1998;24:101-107.
18. Ekman B, Nystrom F, Arnqvist HJ. Circulating IGF-I concentrations are low and not correlated to glycaemic control in adults with type 1 diabetes. Eur J Endocrinol 2000;143:505-510.
19. Cortizo AM, Lee PD, Cedola NV, et al. Relationship between non-enzymatic glycosylation and changes in serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in patients with type 2 diabetes mellitus. Acta Diabetol 1998;35:85-90.
20. Tan K, Baxter RC. Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age. J Clin Endocrinol Metab 1986;63:651-655.
21. Miell JP, Taylor AM, Zini M, et al. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J Clin Endocrinol Metab 1993;76:950-955.
22. Valimaki M Liewendahl, Karonen SL, et al. Concentrations of somatomedin-C and triiodothyronine in patients with thyroid dysfunction and nonthyroidal illnesses. J Endocrinol Invest 1990;13:155-159.
23. Mohnike KL, Kluba U, Mittler U, et al. Serum levels of insulinlike growth factor-I, -II and insulin-like growth factor binding proteins-2 and -3 in children with acute lymphoblastic leukaemia. Eur J Pediatr 1996;155:81-86.
24. Attard-Montalto SP, Camacho-Hubner C, Cotterill AM, et al. Changes in protein turnover, IGF-I and IGF binding proteins in children with cancer. Acta Paediatr 1998;87:54-60.
25. Lee PD, Hintz RL, Sperry JB, et al. IGF binding proteins in growth-retarded children with chronic renal failure. Pediatr Res 1989;26:308-315.
26. Lepenies J, Wu Z, Stewart PM, et al. IGF-1, IGFBP-3 and ALS in adult patients with chronic kidney disease. Growth Horm IGF Res 2010;20:93-100.
27. Jorgensen JO, Pedersen SB, Borglum J, et al. Serum concentrations of insulin-like growth factors (IGFs), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: a doubleblind, placebo-controlled study. Eur J Endocrinol 1995;133:65-70.